ENXTPA:DBVBiotechsIs DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?December 01, 2023Just because a business does not make any money, does not mean that the stock will go down. For example, although...
ENXTPA:ALNOVBiotechsIs Novacyt (EPA:ALNOV) In A Good Position To Deliver On Growth Plans?November 28, 2023There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
ENXTPA:ALVALBiotechsValbiotis SA (EPA:ALVAL): Are Analysts Optimistic?November 24, 2023Valbiotis SA ( EPA:ALVAL ) is possibly approaching a major achievement in its business, so we would like to shine some...
ENXTPA:VLABiotechsValneva Third Quarter 2023 Earnings: Misses ExpectationsNovember 14, 2023Valneva ( EPA:VLA ) Third Quarter 2023 Results Key Financial Results Revenue: €38.1m (down 76% from 3Q 2022). Net loss...
ENXTPA:OSEBiotechsFurther weakness as OSE Immunotherapeutics (EPA:OSE) drops 11% this week, taking three-year losses to 54%November 11, 2023It is a pleasure to report that the OSE Immunotherapeutics SA ( EPA:OSE ) is up 51% in the last quarter. But that...
ENXTPA:ALCLSBiotechsRetail investors who hold 36% of Cellectis S.A. (EPA:ALCLS) gained 207%, institutions profited as wellNovember 03, 2023Key Insights Cellectis' significant retail investors ownership suggests that the key decisions are influenced by...
ENXTPA:ALQGCBiotechsQuantum Genomics Société Anonyme (EPA:ALQGC): When Will It Breakeven?October 29, 2023With the business potentially at an important milestone, we thought we'd take a closer look at Quantum Genomics Sociét...
ENXTPA:ADOCBiotechsAdocia SA's (EPA:ADOC) market cap dropped €13m last week; Retail investors bore the bruntOctober 21, 2023Key Insights The considerable ownership by retail investors in Adocia indicates that they collectively have a greater...
ENXTPA:IVABiotechsShareholders in Inventiva (EPA:IVA) have lost 71%, as stock drops 12% this past weekOctober 21, 2023It's not possible to invest over long periods without making some bad investments. But really big losses can really...
ENXTPA:DBVBiotechsHedge funds owners may consider drastic measures as DBV Technologies S.A.'s (EPA:DBV) recent €27m drop adds to long-term lossesOctober 21, 2023Key Insights Significantly high institutional ownership implies DBV Technologies' stock price is sensitive to their...
ENXTPA:VLABiotechsValneva SE's (EPA:VLA) stock price dropped 10% last week; individual investors would not be happyOctober 20, 2023Key Insights Valneva's significant individual investors ownership suggests that the key decisions are influenced by...
ENXTPA:ALERSBiotechsEurobio Scientific Société anonyme's (EPA:ALERS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?October 14, 2023Eurobio Scientific Société anonyme (EPA:ALERS) has had a rough month with its share price down 11%. However, the...
ENXTPA:ABNXBiotechsIs ABIONYX Pharma (EPA:ABNX) Using Too Much Debt?October 12, 2023Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
ENXTPA:NANOBiotechsDespite currently being unprofitable, Nanobiotix (EPA:NANO) has delivered a 64% return to shareholders over 1 yearOctober 07, 2023It certainly might concern Nanobiotix S.A. ( EPA:NANO ) shareholders to see the share price down 31% in just 30 days...
ENXTPA:OSEBiotechsWe Think OSE Immunotherapeutics (EPA:OSE) Has A Fair Chunk Of DebtOctober 02, 2023The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
ENXTPA:IPHBiotechsAnalysts' Revenue Estimates For Innate Pharma S.A. (EPA:IPH) Are Surging HigherSeptember 30, 2023Innate Pharma S.A. ( EPA:IPH ) shareholders will have a reason to smile today, with the analysts making substantial...
ENXTPA:POXELBiotechsPoxel Reports First Half 2023 EarningsSeptember 29, 2023Poxel ( EPA:POXEL ) First Half 2023 Results Key Financial Results Net loss: €26.2m (loss widened by 96% from 1H 2022...
ENXTPA:ALGENBiotechsgenOway Société anonyme Reports First Half 2023 EarningsSeptember 29, 2023genOway Société anonyme ( EPA:ALGEN ) First Half 2023 Results Key Financial Results Revenue: €9.33m (down 6.7% from 1H...
ENXTPA:TNGBiotechsInsiders are the top stockholders in Transgene SA (EPA:TNG), and the recent 15% drop might have disappointed themSeptember 27, 2023Key Insights Significant insider control over Transgene implies vested interests in company growth 60% of the company...
ENXTPA:ALGENBiotechsWe Think genOway Société anonyme (EPA:ALGEN) Can Stay On Top Of Its DebtSeptember 27, 2023Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
ENXTPA:GNFTBiotechsHealth Check: How Prudently Does Genfit (EPA:GNFT) Use Debt?September 22, 2023David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
ENXTPA:ALPATBiotechsWe Might See A Profit From Plant Advanced Technologies SA (EPA:ALPAT) SoonSeptember 20, 2023With the business potentially at an important milestone, we thought we'd take a closer look at Plant Advanced...
ENXTPA:ADOCBiotechsAdocia Reports First Half 2023 EarningsSeptember 20, 2023Adocia ( EPA:ADOC ) First Half 2023 Results Key Financial Results Revenue: €3.90m (down 63% from 1H 2022). Net loss...
ENXTPA:ALACTBiotechsActicor Biotech SAS (EPA:ALACT) Could Be Less Than A Year Away From ProfitabilitySeptember 02, 2023We feel now is a pretty good time to analyse Acticor Biotech SAS' ( EPA:ALACT ) business as it appears the company may...